UBS downgraded Crane to Neutral from Buy with a price target of $120, down from $132. The analyst thinks Crane’s path to unlocking further shareholder value is "likely bumpier and slower in the near term." The firm sees a risk of "relatively subdued early standalone valuation" for NXT due to lack of clear comps and target investors, which could potentially bring a more attractive entry point post separation. UBS thinks a further multiple re-rating of Crane shares will largely hinge on future acquisition execution at both companies, as well as evidence of sustained outgrowth and margin improvement.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CR: